HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation.

AbstractBACKGROUND:
The present study evaluated performance characteristics of liver stiffness measurement (LSM) by FibroScan in patients with different stages of nonalcoholic fatty liver disease (NAFLD).
PATIENTS AND METHODS:
A total of 307 subjects (120 NAFLD, 85 NAFLD related cirrhosis, and 102 healthy controls) were studied.
RESULTS:
In NAFLD patients, LSM had significant correlation with fibrosis (r = 0.68, p < 0.001), and increased progressively with increasing fibrosis (p < 0.001). However, the difference between stage 1 and stage 2 fibrosis was not significant (p = 0.07). The LSM in NAFLD without fibrosis and healthy controls was similar (p = 0.37). The areas under receiver-operating characteristics (AUROC) curve of LSM for stages ≥1, ≥2, ≥3, and 4 were 0.82, 0.85, 0.94, and 0.96, respectively. The best LSM (kPa) cut-offs for fibrosis stages ≥1, ≥2, ≥3 and 4 were 6.1, 7.0, 9.0, and 11.8, respectively. The negative predictive value of LSM for excluding advanced fibrosis was 95%. For advanced fibrosis, the AUROC curve of LSM was 0.94, followed by FIB-4 (0.75), BARD score (0.68), NAFLD fibrosis score (0.66), and aspartate platelet ratio index (0.60). In multivariate analysis, LSM was the only independent predictor of advanced fibrosis (odds ratio 1.47). In patients with NAFLD cirrhosis, LSM correlated significantly with Child-Pugh score (r = 0.40, p < 0.001), serum bilirubin (r = 0.34, p = 0.02), and grades of esophageal varices (r = 0.23, p = 0.04).
CONCLUSION:
LSM is a useful tool for evaluation of patients with NAFLD, and is the best among other non-invasive predictors of liver fibrosis.
AuthorsRamesh Kumar, Archana Rastogi, Manoj Kumar Sharma, Vikram Bhatia, Pankaj Tyagi, Praveen Sharma, Hitendra Garg, K N Chandan Kumar, Chhagan Bihari, Shiv Kumar Sarin
JournalDigestive diseases and sciences (Dig Dis Sci) Vol. 58 Issue 1 Pg. 265-74 (Jan 2013) ISSN: 1573-2568 [Electronic] United States
PMID22790906 (Publication Type: Journal Article)
Chemical References
  • Biomarkers
Topics
  • Adult
  • Biomarkers
  • Biomechanical Phenomena
  • Biopsy
  • Elasticity Imaging Techniques
  • Fatty Liver (pathology)
  • Female
  • Humans
  • Liver (pathology)
  • Liver Cirrhosis (pathology)
  • Male
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease
  • Predictive Value of Tests

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: